|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn866584777 |
003 |
OCoLC |
005 |
20231117044942.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
131115s2014 ne a ob 000 0 eng d |
040 |
|
|
|a UKMGB
|b eng
|e rda
|e pn
|c UKMGB
|d IDEBK
|d OPELS
|d N$T
|d E7B
|d CDX
|d YDXCP
|d GGVRL
|d OCLCF
|d OCLCQ
|d TXI
|d ITD
|d MERER
|d OCLCQ
|d SAV
|d U3W
|d D6H
|d LQU
|d S2H
|d OCLCO
|d UX1
|d TUHNV
|d OCLCO
|d OCLCA
|d OCLCO
|d OCL
|d OCLCQ
|
015 |
|
|
|a GBB3B7044
|2 bnb
|
016 |
7 |
|
|a 016585958
|2 Uk
|
016 |
7 |
|
|a 016627784
|2 Uk
|
019 |
|
|
|a 1105191812
|a 1105561194
|
020 |
|
|
|a 9780124115484
|q (electronic bk.)
|
020 |
|
|
|a 0124115489
|q (electronic bk.)
|
020 |
|
|
|a 9780124115620
|q (electronic bk.)
|
020 |
|
|
|a 0124115624
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)866584777
|z (OCoLC)1105191812
|z (OCoLC)1105561194
|
050 |
|
4 |
|a RS424
|
060 |
|
4 |
|a QV 754
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.19
|2 23
|
100 |
0 |
|
|a Thorsteinn Loftsson,
|e author.
|
245 |
1 |
0 |
|a Drug stability for pharmaceutical scientists /
|c by Thorsteinn Loftsson.
|
264 |
|
1 |
|a Amsterdam :
|b Academic Press,
|c 2014.
|
300 |
|
|
|a 1 online resource :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
336 |
|
|
|a still image
|b sti
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a CIP data: resource not viewed.
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
|
|a Chapter 1. Introduction -- chapter 2. Principles of drug degradation -- chapter 3. Degradation pathways -- chapter 4. Drug degradation in semisolid dosage forms -- chapter 5. Stability of peptides and proteins -- chapter 6. Drug degradation in solid state -- chapter 7. Stability testing -- chapter 8. Problems.
|
520 |
|
|
|a A clear and easy-to-follow guide on drug degradation in pharmaceutical formulation. This book features valuable content on both aqueous and solid drug solutions, the stability of proteins and peptides, acid-base catalyzed and solvent catalyzed reactions, how drug formulation can influence drug stability, and the influence of external factors on reaction rates.
|
650 |
|
0 |
|a Drug stability.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
1 |
2 |
|a Drug Stability
|0 (DNLM)D004355
|
650 |
2 |
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
6 |
|a M�edicaments
|x Stabilit�e.
|0 (CaQQLa)201-0038460
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Pharmaceutical chemistry.
|2 fast
|0 (OCoLC)fst01060115
|
650 |
|
7 |
|a Drug stability.
|2 fast
|0 (OCoLC)fst00898707
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780124115484
|z Texto completo
|